AGL - AGILON HEALTH INC. (NYSE: AGL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against agilon health inc. | Benzinga
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of agilon health, inc. (NYSE:AGL)?
- Did you purchase your shares pursuant and/or traceable to the Company's May 2023 SPO, or between January 9, 2023 and January 4, 2024, inclusive?
- Did you lose money in your investment in agilon health, inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors that purchased or otherwise acquired: (a) agilon health, inc. ("agilon" or the "Company") common stock between January 9, 2023 and January 4, 2024, both dates inclusive (the "Class Period"); and/or (b) agilon common stock pursuant and/or traceable to the Company's May 2023 secondary public offering (the "SPO"). The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 (the "Complaint").
If you purchased or acquired agilon common stock, including pursuant to the SPO, and/or would like to discuss your legal rights and options please visit agilon health, inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter ...
AGL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against agilon health, inc.>Full story available on Benzinga.com